Ready to ramp up your syringe production to meet COVID-19 vaccination demand?

We got you covered

As the biggest vaccination effort in history is ramping up around the globe, syringe producers are asked to quickly scale up their manufacturing operations to deliver these medical devices much needed for administrating the vaccine. Borealis with its Bormed™ range of polyolefins offers solutions for low dead space syringes for vaccine administration (1ml) and low volume syringes for vaccine preparation (3ml, 5ml).

Bormed stands for our Commitment, Conformance and Service to the healthcare industry. We offer material and design engineers expert advice and unrivalled access to data such as rheology, mould flow, shrinkage and sterilisation. We are committed to your project success and offer locked-in recipes and security of supply for up to five years. On request we can provide you with Bormed regulatory analysis reports, extractable data, composition disclosures and Letter of Authority for the US DMF.

Bormed™ also helps material engineers stay one step ahead. Our newest solution is the Bornewables line of products, offering circular Bormed polyolefins produced with renewable feedstock derived entirely from waste and residue streams.

Would you like to learn more about our Bormed portfolio for syringes?
Download the presentation.

Any further questions? Then please reach out to our healthcare team at:
e-mail: bormed@borealisgroup.com